Evidence map›Paper›PMID 41312005›Full record

ArticleJournal of clinical biochemistry and nutrition2025

Targeting

Hideki Mori, Chikara Iino, Takeshi Fujieda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. The Effects ofJournal of clinical medicine · 2026
    Review
  3. Helicobacter pylori Management in Older Adults: Current Perspectives From Japan.The Korean journal of helicobacter and upper gastrointestinal research · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hideki MoriDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Chikara IinoDepartment of Gastroenterology and Hematology, Graduate School of Medicine, Hirosaki University, 53 Honcho, Hirosaki, Aomori 036-8560, Japan.
Takeshi FujiedaDepartment of Internal Medicine, Kitaibaraki City Hospital, 1050 Sekinamicho Sekimotoshimo, Kitaibaraki, Ibaraki 319-1711, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver impairment can alter the metabolic capacity of the organ significantly, potentially affecting the efficacy and safety of

Indexed as

hepatitis C virus (HCV)H. pylori eradicationliver impairmentnon-alcoholic fatty liver disease (NAFLD)non-alcoholic steatohepatitis (NASH)

Identifiers

PMID41312005
PMCPMC12646836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.